HC may inhibit PI3K/Akt/mTOR and ERK1/2 signaling pathways in human lung cancer cells [53], while IL17A can inhibit PI3K/Akt/mTOR-mediated autophagy, which causes lung inflammation and fibrosis [54]. Here, MAPK3 is linked to lung carcinoma.